These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 20224524

  • 1. Aliskiren/valsartan (Valturna) for hypertension.
    Med Lett Drugs Ther; 2009 Nov 30; 51(1326):94-5. PubMed ID: 20224524
    [No Abstract] [Full Text] [Related]

  • 2. Dual inhibition of the renin system by aliskiren and valsartan.
    Oparil S, Yarows SA, Patel S, Zhang J, Satlin A.
    Lancet; 2007 Sep 29; 370(9593):1126-7. PubMed ID: 17905160
    [No Abstract] [Full Text] [Related]

  • 3. Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan.
    Pool JL, Schmieder RE, Azizi M, Aldigier JC, Januszewicz A, Zidek W, Chiang Y, Satlin A.
    Am J Hypertens; 2007 Jan 29; 20(1):11-20. PubMed ID: 17198906
    [Abstract] [Full Text] [Related]

  • 4. The antihypertensive effectiveness and safety of dual RAAS blockade with aliskiren and valsartan.
    Chrysant SG.
    Drugs Today (Barc); 2010 Mar 29; 46(3):151-62. PubMed ID: 20467589
    [Abstract] [Full Text] [Related]

  • 5. Comparative efficacy of aliskiren/valsartan vs valsartan in nocturnal dipper and nondipper hypertensive patients: a pooled analysis.
    Giles TD, Alessi T, Purkayastha D, Zappe D.
    J Clin Hypertens (Greenwich); 2012 May 29; 14(5):299-306. PubMed ID: 22533656
    [Abstract] [Full Text] [Related]

  • 6. Aliskiren and valsartan in stage 2 hypertension: subgroup analysis of a randomized, double-blind study.
    Yarows SA, Oparil S, Patel S, Fang H, Zhang J.
    Adv Ther; 2008 Dec 29; 25(12):1288-302. PubMed ID: 19066757
    [Abstract] [Full Text] [Related]

  • 7. Aliskiren/valsartan combination for the treatment of cardiovascular and renal diseases.
    Yarows SA.
    Expert Rev Cardiovasc Ther; 2010 Jan 29; 8(1):19-33. PubMed ID: 20030022
    [Abstract] [Full Text] [Related]

  • 8. Two amlodipine/ARB combinations for hypertension.
    Med Lett Drugs Ther; 2007 Dec 17; 49(1276):101-2. PubMed ID: 18084152
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial.
    Oparil S, Yarows SA, Patel S, Fang H, Zhang J, Satlin A.
    Lancet; 2007 Jul 21; 370(9583):221-229. PubMed ID: 17658393
    [Abstract] [Full Text] [Related]

  • 10. Aliskiren/hydrochlorothiazide (Tekturna HCT) for hypertension.
    Med Lett Drugs Ther; 2008 Aug 25; 50(1293):65-6. PubMed ID: 18719523
    [No Abstract] [Full Text] [Related]

  • 11. Exforge HCT.
    Med Lett Drugs Ther; 2009 Jun 15; 51(1314):47. PubMed ID: 19528888
    [No Abstract] [Full Text] [Related]

  • 12. Amlodipine/valsartan single-pill combination: a review of its use in the management of hypertension.
    Frampton JE, Scott LJ.
    Am J Cardiovasc Drugs; 2009 Jun 15; 9(5):309-30. PubMed ID: 19791840
    [Abstract] [Full Text] [Related]

  • 13. Aliskiren: a new inhibitor of renin-angiotensin aldosterone system activity.
    Dalla Vestra M, Simioni N, Masiero A.
    Minerva Endocrinol; 2009 Dec 15; 34(4):333-8. PubMed ID: 20046162
    [Abstract] [Full Text] [Related]

  • 14. [Dual blockade of the renin-angiotensin system in hypertensive treatment: yes].
    Middeke M.
    Dtsch Med Wochenschr; 2012 Nov 15; 137(48):2498. PubMed ID: 23168983
    [No Abstract] [Full Text] [Related]

  • 15. Long-term safety, tolerability and efficacy of aliskiren in combination with valsartan in patients with hypertension: a 6-month interim analysis.
    Chrysant SG, Murray AV, Hoppe UC, Dattani D, Patel S, Hsu H, Zhang J.
    Curr Med Res Opin; 2008 Apr 15; 24(4):1039-47. PubMed ID: 18307835
    [Abstract] [Full Text] [Related]

  • 16. Aliskiren, the first approved renin inhibitor: Clinical application and safety in the treatment of hypertension.
    Riccioni G, Vitulano N, D'Orazio N, Bellocci F.
    Adv Ther; 2009 Jul 15; 26(7):700-10. PubMed ID: 19649581
    [Abstract] [Full Text] [Related]

  • 17. Hemodynamic and hormonal changes to dual renin-angiotensin system inhibition in experimental hypertension.
    Moniwa N, Varagic J, Ahmad S, VonCannon JL, Simington SW, Wang H, Groban L, Brosnihan KB, Nagata S, Kato J, Kitamura K, Gomez RA, Lopez ML, Ferrario CM.
    Hypertension; 2013 Feb 15; 61(2):417-24. PubMed ID: 23232645
    [Abstract] [Full Text] [Related]

  • 18. Aliskiren in the management of hypertension.
    Barrios V, Escobar C.
    Am J Cardiovasc Drugs; 2010 Feb 15; 10(6):349-58. PubMed ID: 21090828
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antihypertensive therapies.
    Smith RE, Ashiya M.
    Nat Rev Drug Discov; 2007 Aug 15; 6(8):597-8. PubMed ID: 17821828
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.